On June 02, 2026, Tenet Healthcare Corp THC shares fell 3.8% to $163.60. This decline is notable within the context of a 52-week trading range of $146.60 to $247.21, reflecting a significant downward trend in the past month and year-to-date. The stock has experienced a year-to-date decline of 17.7% and a one-month decline of 10.7%.
- GF Value™ verdict: Current price is $163.60, which is 0.4% undervalued compared to the GF Value™ of $164.27.
- GF Score™ is 80/100, indicating a strong overall performance relative to peers.
- Most notable signal: Insiders sold $12.5M in the last 3 months, suggesting a lack of confidence in short-term performance.
Is THC Overvalued or Undervalued?
The current price of Tenet Healthcare Corp at $163.60 is slightly below the GF Value™ estimate of $164.27, suggesting that the stock is 0.4% undervalued. This indicates a marginal margin of safety for potential investors. The GF Valuation label classifies the stock as fairly valued, which implies that while there is a slight opportunity for upside, the current valuation does not present a significant bargain. GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates.
However, caution is warranted as the stock has been on a downward trajectory, and the recent insider selling of $12.5 million raises questions about the company's near-term prospects. Investors may find a small opportunity here, but they should consider the potential risks associated with the company’s current financial health and market sentiment.
How Does THC's Valuation Compare to Its History?
| Metric | Current | Historical |
|---|---|---|
| P/E (TTM) | 8.5x | 10.4x |
| Forward P/E | 9.2x | N/A |
The current P/E (TTM) ratio of 8.5x is significantly below its 5-year median P/E of 10.4x, indicating that the stock is trading at a discount to its historical valuation. This P/E analysis aligns with the GF Value™ verdict, suggesting that the stock may be undervalued relative to its historical performance, providing a potential opportunity for investors. However, the low P/E also reflects market concerns about the company's future growth and profitability.
What Does THC's GF Score™ Tell Us?
| Metric | Rating |
|---|---|
| GF Score™ | 80/100 |
| Financial Strength | 5/10 |
| Profitability | 7/10 |
| Growth | 6/10 |
| Valuation | 7/10 |
| Momentum | 7/10 |
The GF Score™ of 80/100 indicates that Tenet Healthcare Corp has strong potential for long-term returns, with its profitability and valuation ranks being relatively strong. However, its financial strength rating of 5/10 highlights potential weaknesses in its capital structure or liquidity, suggesting that while the company may be positioned well in terms of profitability and valuation, it faces challenges in maintaining financial robustness. The growth rank of 6/10 indicates moderate growth prospects, which could impact future performance.
What Are Insiders Doing with THC Stock?
In recent months, insiders at Tenet Healthcare Corp have sold a total of $12.5 million in stock, with no recorded purchases during the same period. This pattern of selling may suggest a lack of confidence among insiders regarding the company’s short-term outlook. When insiders sell significant amounts of stock, it can signal potential concerns about future performance, making it an important factor for investors to consider.
The absence of insider buying further amplifies the cautious sentiment surrounding the stock, as it may indicate that insiders do not see immediate value or stability in the company's prospects.
What This Means for Investors
Based on the current assessment, Tenet Healthcare Corp is considered fairly valued as per the GF Value™ estimate. While the stock shows a slight undervaluation, the recent downward trend and insider selling patterns suggest that investors should proceed cautiously. The company holds potential, but the risks associated with its financial health and market sentiment cannot be overlooked.
For the complete analysis, visit the Tenet Healthcare Corp THC stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions
What is THC's GF Score™?
THC's GF Score™ is 80/100, indicating a strong overall performance relative to its peers and suggesting potential for higher long-term returns.
Is THC overvalued or undervalued?
THC is currently considered fairly valued based on the GF Value™ estimate, with a slight 0.4% undervaluation indicating a minor opportunity.
What is THC's P/E ratio?
THC's P/E (TTM) ratio is 8.5x, which is 18% below its 5-year median P/E of 10.4x, indicating that the stock is trading at a discount to its historical valuation.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
